Published in Semin Urol on November 01, 1988
Weekly chemotherapy in advanced prostatic cancer. Br J Cancer (1993) 0.93
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 16.03
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12
Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science (1992) 5.18
Retracted Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J Immunol (1990) 3.76
Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol (1993) 3.51
Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04
Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03
IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol (1992) 2.67
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
High-dose chemotherapy for breast cancer. Ann Intern Med (1996) 2.09
Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest (1993) 2.00
Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol (1993) 2.00
Gamma delta T lymphocytes in human tuberculosis. J Infect Dis (1992) 1.78
Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med (1999) 1.77
Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med (1991) 1.77
The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med (1995) 1.74
Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun (1993) 1.72
Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J Exp Med (1990) 1.71
Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol (1995) 1.69
Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med (1996) 1.68
Activation of mouse T-helper cells induces abundant preproenkephalin mRNA synthesis. Science (1986) 1.60
Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods (1993) 1.60
Increasing incidence of right-sided lesions in colorectal cancer. Am J Surg (1979) 1.58
High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis (1996) 1.51
A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production. J Exp Med (2001) 1.48
Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest (1993) 1.47
A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide. J Clin Oncol (1989) 1.46
Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infect Immun (1993) 1.44
Regulation of immunoglobulin (Ig)E synthesis in the hyper-IgE syndrome. J Clin Invest (1990) 1.42
IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. J Immunol (1993) 1.39
APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J Immunol (1999) 1.38
Expression of murine and human granulocyte-macrophage colony-stimulating factors in S. cerevisiae: mutagenesis of the potential glycosylation sites. EMBO J (1986) 1.36
Functional heterogeneity among human inducer T cell clones. J Immunol (1988) 1.34
Parallel regulation of IL-4 and IL-5 in human helminth infections. J Immunol (1992) 1.33
Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer (1993) 1.31
Impingement syndrome in the absence of rotator cuff tear (stages 1 and 2). Orthop Clin North Am (1987) 1.30
Importance of the carrier state as a source of Staphylococcus aureus in wound sepsis. J Hyg (Lond) (1969) 1.29
COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth. Science (1989) 1.27
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17. Ann Oncol (2008) 1.24
The significance of a "positive" rectal examination in acute appendicitis. Dis Colon Rectum (1979) 1.24
Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int Immunol (1992) 1.18
Antibody against interleukin-6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis. Infect Immun (1994) 1.18
Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin-4. J Immunol Methods (1989) 1.17
Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study. J Clin Oncol (1990) 1.17
Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis (1991) 1.17
Induction of human IgE synthesis by CD4+ T cell clones. Requirement for interleukin 4 and low molecular weight B cell growth factor. J Exp Med (1989) 1.14
Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem (1995) 1.13
Fractalkine protein localization and gene expression in mouse brain. J Neurosci Res (2003) 1.11
Myocardial toxic effects during recombinant interleukin-2 therapy. J Natl Cancer Inst (1989) 1.10
Early expression of cytokines in lymph nodes after treatment in vivo with Staphylococcus enterotoxin B. J Immunol Methods (1994) 1.10
Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology (1993) 1.09
IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis (1993) 1.08
Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis. J Infect Dis (1994) 1.08
Human eosinophils synthesize and secrete interleukin-6, in vitro. Blood (1992) 1.07
Cancer prognostics: past, present and p27. Nat Med (1997) 1.06
Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine (1992) 1.06
Tamoxifen: trials, tribulations, and trade-offs. J Natl Cancer Inst (1994) 1.05
Experimental intestinal atresia. Surgery (1968) 1.03
Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol (1995) 1.02
Local cytokine production in a murine model of Escherichia coli pyelonephritis. J Clin Invest (1992) 1.01
IL-18 receptors, their role in ligand binding and function: anti-IL-1RAcPL antibody, a potent antagonist of IL-18. J Immunol (2000) 1.00
Mechanism of autocrine stimulation in hematopoietic cells producing interleukin-3 after retrovirus-mediated gene transfer. Mol Cell Biol (1989) 1.00
The absence of a relationship between cholecystectomy and the subsequent occurrence of cancer of the proximal colon. Dis Colon Rectum (1983) 1.00
Adhesion of Plasmodium falciparum-infected erythrocytes to human cells and secretion of cytokines (IL-1-beta, IL-1RA, IL-6, IL-8, IL-10, TGF beta, TNF alpha, G-CSF, GM-CSF. Scand J Immunol (1995) 1.00
Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi. J Infect Dis (1993) 0.97
Acromioplasty for impingement with an intact rotator cuff. J Bone Joint Surg Br (1988) 0.93
Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis. J Clin Invest (1991) 0.88
Interleukin-10 in amniotic fluid at midtrimester: immune activation and suppression in relation to fetal growth. Am J Obstet Gynecol (1994) 0.88
Factors influencing perineal wound healing after proctectomy. Am J Surg (1983) 0.88
A role for stem cell factor (SCF): c-kit interaction(s) in the intestinal tract response to Salmonella typhimurium infection. J Exp Med (1996) 0.87
A hard look at colonoscopy. Am J Surg (1977) 0.87
A second look at colonoscopy: indications, failures, and costs. Arch Surg (1982) 0.86
Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer. Blood (1991) 0.86
Interleukin-3 in bronchial biopsies from nonasthmatics and patients with mild and allergen-induced asthma. Am J Respir Crit Care Med (1996) 0.83
Generalized peritonitis due to a ruptured splenic abscess. Am J Surg (1966) 0.83
In vitro synthesis of IL-4 by human CD4+ T cells requires repeated antigenic stimulation. Cell Immunol (1993) 0.83
A limited sampling strategy for cyclophosphamide pharmacokinetics. Cancer Res (1989) 0.82
Kinetics of serum and cellular interleukin-5 in posttreatment eosinophilia of patients with lymphatic filariasis. J Infect Dis (1993) 0.82
Neutrophilic differentiation induced by human upper airway fibroblast-derived granulocyte/macrophage colony-stimulating factor (GM-CSF). Am J Respir Cell Mol Biol (1991) 0.82
Similar RANTES levels in healthy and asthmatic airways by immunoassay and in situ hybridization. Am J Respir Crit Care Med (1997) 0.81
Adverse effects of salt and water retention on pulmonary function in patients with multiple trauma. J Trauma (1973) 0.81
Effect of phenoxybenzamine on endotoxic shock in dogs. II. Metabolic changes. J Trauma (1969) 0.80
Augmentation of granulocyte/macrophage colony-stimulating factor expression by ultraviolet irradiation is mediated by interleukin 1 in Pam 212 keratinocytes. J Invest Dermatol (1991) 0.79
A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer. Breast Cancer Res Treat (1991) 0.79
Elective resection for colorectal cancer in Vermont: 1971--1975. Am J Surg (1980) 0.78
Compartment syndrome of the upper arm. Orthopedics (1994) 0.78
Response of the rat to intraperitoneal injection of E. coli endotoxin. J Surg Res (1967) 0.78
Human upper airway epithelial cell-derived granulocyte-macrophage colony-stimulating factor induces histamine-containing cell differentiation of human progenitor cells. Int Arch Allergy Appl Immunol (1991) 0.78
Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma. J Natl Cancer Inst (1991) 0.78
Lymphokine profile in bone marrow transplant recipients. Blood (1991) 0.78
Linkage of interleukin-4 and interleukin-5 production in human helminth infections. Trans Assoc Am Physicians (1991) 0.77
Tamoxifen: five versus ten years--is the end in sight? J Natl Cancer Inst (2001) 0.76
Cytokine production at the site of disease in chronic eosinophilic pneumonitis. Am J Respir Crit Care Med (1996) 0.76
Antisense RNA inhibition of hematopoietic growth factor production. Growth Factors (1991) 0.75
CT evaluation of patients during treatment of advanced non-small cell lung carcinoma. Am J Clin Oncol (1986) 0.75
Clinical staging of rectal cancer. Am J Surg (1980) 0.75
Multiple malignant carcinoids of the stomach. Arch Surg (1980) 0.75
Blood pressure response to the portal infusion of angiotensin-II. Surg Forum (1966) 0.75